Bristol-Myers Squibb Co. is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. More details at: http://www.bms.com.

Should Bristol-Myers Squibb shares be given the Cheapest Stocks Today In The S&P 500 label? To start, we see that the recent trading price for BMY stock is $63.70 (as of 8/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $8.16/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Bristol-Myers Squibb produced $6.51/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $6.4/share. Comparing these various earnings metrics against the stock price, we end up with a PE ratio of 10.0 for the TTM Median method, 7.8 for price to earnings using MRQ annualized, and 9.8 for current price/TTM earnings. Based on BMY's history, that recent TTM PE is low relative to the historical average, with the recent PE 47.6% lower than the average (TTM method) of 18.7.

Pfizer Inc. is a research-based global biopharmaceutical company. Co. is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. More details at: http://www.pfizer.com.

Should Pfizer shares be given the Cheapest Stocks Today In The S&P 500 label? To start, we see that the recent trading price for PFE stock is $26.31 (as of 8/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $3.08/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Pfizer produced $3.05/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $3.04/share. Comparing these various earnings metrics against the stock price, we end up with a PE ratio of 8.7 for the TTM Median method, 8.5 for price to earnings using MRQ annualized, and 8.6 for current price/TTM earnings. Based on PFE's history, that recent TTM PE is low relative to the historical average, with the recent PE 28.9% lower than the average (TTM method) of 12.1.

CF Industries Holdings, Inc. is a manufacturer of hydrogen and nitrogen products. It owns and operates eight nitrogen manufacturing facilities in North America, including six nitrogen manufacturing facilities in the U.S., and two in Canada. Its segments include Ammonia, Granular Urea, UAN, AN and Other. The Ammonia segment produces anhydrous ammonia (ammonia), which is the base product that it manufactures, containing 82% nitrogen and 18% hydrogen. The results of its Ammonia segment consist of sales of ammonia to external customers for its nitrogen content as a fertilizer, in emissions control and in other industrial applications. More details at: http://www.cfindustries.com.

Should CF Industries Holdings shares be given the Cheapest Stocks Today In The S&P 500 label? To start, we see that the recent trading price for CF stock is $120.01 (as of 8/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $18.92/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, CF Industries Holdings produced $13.89/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $13.96/share. Comparing these various earnings metrics against the stock price, we end up with a PE ratio of 8.6 for the TTM Median method, 6.3 for price to earnings using MRQ annualized, and 8.6 for current price/TTM earnings. Based on CF's history, that recent TTM PE is low relative to the historical average, with the recent PE 59.0% lower than the average (TTM method) of 21.0.

APA Corporation is an independent energy company. Co. owns subsidiaries that explore for and produce oil and natural gas in the U.S., Egypt, and the United Kingdom, and that explore for oil and natural gas offshore Suriname. Co.'s upstream business has oil and gas operations in three geographic areas: the U.S., Egypt and offshore the United Kingdom in the North Sea (North Sea). It also has active exploration and appraisal operations ongoing in Suriname, as well as interests in Uruguay and other international locations. It maintains a diversified asset portfolio, including conventional and unconventional, onshore and offshore, oil and natural gas exploration and production interests. More details at: http://www.apachecorp.com.

Should APA shares be given the Cheapest Stocks Today In The S&P 500 label? To start, we see that the recent trading price for APA stock is $39.97 (as of 8/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $7.56/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, APA produced $5.11/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $4.64/share. Comparing these various earnings metrics against the stock price, we end up with a PE ratio of 8.6 for the TTM Median method, 5.3 for price to earnings using MRQ annualized, and 7.8 for current price/TTM earnings. Based on APA's history, that recent TTM PE is low relative to the historical average, with the recent PE 59.4% lower than the average (TTM method) of 19.2.

Aptiv PLC is a technology and mobility architecture company. Co. designs and manufactures vehicle components and provides electrical, electronic, and active safety technology solutions to the global automotive and commercial vehicle markets. Its segments include Signal and Power Solutions and Advanced Safety and User Experience. The Signal and Power Solutions segment provides complete design, manufacture, and assembly of the vehicle's electrical architecture, including engineered component products, connectors, wiring assemblies and harnesses, cable management, electrical centers and hybrid high voltage and safety distribution systems. More details at: http://www.delphi.com.

Should Aptiv shares be given the Cheapest Stocks Today In The S&P 500 label? To start, we see that the recent trading price for APTV stock is $48.48 (as of 8/12/2026). The most recent quarter's (MRQ) earnings result, annualized, was $6.52/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Aptiv produced $7.37/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $7.12/share. Comparing these various earnings metrics against the stock price, we end up with a PE ratio of 6.8 for the TTM Median method, 7.4 for price to earnings using MRQ annualized, and 6.6 for current price/TTM earnings. Based on APTV's history, that recent TTM PE is low relative to the historical average, with the recent PE 75.2% lower than the average (TTM method) of 26.6.